Successful concurrent chemoradiotherapy with cisplatin plus …
Emerging
1
Citations7
Refs2019
Year
Search Works
Work Details
- DOI 10.1093/omcr/omz070
- PMID https://pubmed.ncbi.nlm.nih.gov/31374122
- PMCID https://www.ncbi.nlm.nih.gov/pmc/articles/6681131
- OpenAlex ID W2972068975
- Type Article
- Language EN
- Published 01 Aug 2019
- Volume 2019 (8)
- Source Oxford Medical Case Reports
- Publisher Oxford University Press
- FWCI 0.17
- Countries 1
- Institutions 3
- Added 12 Sep 2019
- Updated 28 Oct 2026
External Links
MENU
0
Successful concurrent chemoradiotherapy with cisplatin plus etoposide after incomplete resection for advanced thymic carcinoma
Article 2019 EN Gold
The optimal therapy for advanced thymic carcinoma has long been controversial. Despite that complete (R0) resection is recommend as the first-line treatment, multidisciplinary approach including chemotherapy and radiotherapy should be considered for patients who lost the operation chance or received incomplete resection. Here, we present a case who received concurrent chemoradiotherapy (CCRT) afte…
1
Citations
7
References
3
Authors
0.17
FWCI
Citations by Year
Last 1 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Ling Han | Jinan University (CN) ShenZhen People’s Hospital (CN) | |
| 2 | Baozhu Zhang | Southern Medical University (CN) | |
| 3 | Shihai Wu Corresponding | Jinan University (CN) ShenZhen People’s Hospital (CN) |
Related Works
10Data: OpenAlex